IL18 and pyoderma gangrenosum: Importantly, IFN-γ priming of monocytes from PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome patients induces a pyrin-dependent IL-18 release and JAK inhibitors have a beneficial effects on the skin lesions of these patients.31